- Home
- ASND vs PEN Comparison
ASND vs PEN Comparison
Compare ASND & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- PEN
- Stock Information
- Founded
- ASND 2006
- PEN 2004
- Country
- ASND Denmark
- PEN United States
- Employees
- ASND N/A
- PEN N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- PEN Medical/Dental Instruments
- Sector
- ASND Health Care
- PEN Health Care
- Exchange
- ASND Nasdaq
- PEN Nasdaq
- Market Cap
- ASND 9.1B
- PEN 10.5B
- IPO Year
- ASND 2015
- PEN 2015
- Fundamental
- Price
- ASND $159.39
- PEN $288.89
- Analyst Decision
- ASND Strong Buy
- PEN Strong Buy
- Analyst Count
- ASND 16
- PEN 16
- Target Price
- ASND $213.88
- PEN $299.73
- AVG Volume (30 Days)
- ASND 587.4K
- PEN 525.2K
- Earning Date
- ASND 05-01-2025
- PEN 04-23-2025
- Dividend Yield
- ASND N/A
- PEN N/A
- EPS Growth
- ASND N/A
- PEN N/A
- EPS
- ASND N/A
- PEN 1.08
- Revenue
- ASND $398,509,511.00
- PEN $1,240,100,000.00
- Revenue This Year
- ASND $62.61
- PEN $14.26
- Revenue Next Year
- ASND $72.16
- PEN $14.21
- P/E Ratio
- ASND N/A
- PEN $267.83
- Revenue Growth
- ASND 12.06
- PEN 13.17
- 52 Week Low
- ASND $111.09
- PEN $148.00
- 52 Week High
- ASND $183.00
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ASND 49.26
- PEN 54.30
- Support Level
- ASND $164.24
- PEN $285.27
- Resistance Level
- ASND $183.00
- PEN $296.44
- Average True Range (ATR)
- ASND 7.80
- PEN 9.76
- MACD
- ASND -0.49
- PEN -0.07
- Stochastic Oscillator
- ASND 20.85
- PEN 55.17
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.